comparemela.com

Latest Breaking News On - Abul bashar mohammad khurshid alam - Page 13 : comparemela.com

Bangladesh signs agreement with China to purchase vaccines

Shakib, Mustafiz to play against SL without practice-550995

Shakib, Mustafiz to play against SL without practice Duo bound to complete 14-quarantine Sports Correspondent 4th May, 2021 10:44:27 Bangladesh all-rounder Shakib Al Hasan and pacer Mustafizur Rahman will take part in the upcoming three-match ODI series against Sri Lanka without any preparation as they have to complete 14-day quarantine. Bangladesh Cricket Board official said on Tuesday that the duo with a return home on special arrangements air travel from India to Bangladesh stands suspended but the land border is open with the caveat of 14-day quarantine. “There is no flight at the moment so if they have to come they will have to come on a special arrangement,” BCB chief executive Nizamuddin Chowdhury told reporters on Tuesday.

Renata seeks permission to bring Moderna s Covid-19 vaccine

Renata seeks permission to bring Moderna’s Covid-19 vaccine FILE PHOTO: Walmart pharmacist holds a vial of the Moderna coronavirus disease (COVID-19) vaccine inside a Walmart department store as Walmart and other major US pharmacies take part in the Federal Retail Pharmacy Program, to increase vaccinations in the US in West Haven, Connecticut, US, February 17, 2021. REUTERS/Mike Segar Star Digital Report Star Digital Report Bangladeshi pharmaceutical company Renata Limited has sought permission from the government to bring Moderna s Covid-19 vaccine to the country. Dr Abul Bashar Mohammad Khurshid Alam, director general of the Directorate General of Health Services, shared the information during a programme in Dhaka today.

Beximco-Serum: Talks on to make Oxford vaccines here

Serum Institute of India has been in talks with Beximco about producing the Oxford-AstraZeneca vaccine in Bangladesh. Serum s discussion with its Bangladeshi agent Beximco Pharmaceuticals Ltd is part of an effort to ramp up production as the former struggles to meet the demand in India and the global supply commitments. Beximco has asked Serum about the amount of doses that can be produced here and where the doses would be supplied to, Beximco Managing Director Nazmul Hassan Papon said. Local production requires a large investment. Before making the investment, we need to study its feasibility. It won t be viable if we produce only for the local market. We are waiting for a formal proposal [from Serum], Papon told The Daily Star yesterday.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.